NEW YORK (GenomeWeb News) – Shares of Compugen rose around 73 percent for the month of December to lead all stocks in the GenomeWeb Daily News Index.

Compugen was one of three stocks in the Index to gain more than 20 percent for the month. The other two were Exact Sciences, which climbed 30 percent, and Affymetrix, which rose 23 percent.

Helicos Biosciences had the sharpest drop among the seven stocks that lost value during December. Helicos declined 32 percent, while shares of Accelr8 fell roughly 24 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.